Literature DB >> 8824774

Vaccinia virus DNA replication: a short review.

G Beaud1.   

Abstract

The purpose of this review is to summarize information published since 1990 on DNA replication, recombination and repair of vaccinia virus, a poxvirus. Temperature-sensitive mutations reveal four essential genes related to viral DNA replication: the E9L DNA polymerase, B1R protein kinase, D5R protein, and D4R uracil DNA glycosylase. Other proteins are likely to be also involved in viral DNA replication: the H6R DNA topoisomerase, I3L single stranded-DNA binding protein, H5R virosome-associated protein, and A50R DNA ligase. In addition, several viral-encoded proteins do regulate the level of the deoxyribonucleoside triphosphate pool: the J2R thymidine kinase, A48R thymidylate kinase, 14L and F4L subunits of ribonucleotide reductase, and F2L dUTPase. Despite the apparent simplicity of the mechanism of vaccinia virus DNA replication, several important questions related to the three Rs remain unsolved.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8824774     DOI: 10.1016/0300-9084(96)88195-8

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  16 in total

1.  Identification of polymerase and processivity inhibitors of vaccinia DNA synthesis using a stepwise screening approach.

Authors:  Janice Elaine Y Silverman; Mihai Ciustea; Abigail M Druck Shudofsky; Florent Bender; Robert H Shoemaker; Robert P Ricciardi
Journal:  Antiviral Res       Date:  2008-06-20       Impact factor: 5.970

Review 2.  DNA virus replication compartments.

Authors:  Melanie Schmid; Thomas Speiseder; Thomas Dobner; Ramon A Gonzalez
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

3.  Diversity in the acute CD8 T cell response to vaccinia virus in humans.

Authors:  Lichen Jing; Tiana M Chong; Christopher L McClurkan; Jay Huang; Brian T Story; David M Koelle
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

4.  Phosphorylation of herpes simplex virus 1 dUTPase upregulated viral dUTPase activity to compensate for low cellular dUTPase activity for efficient viral replication.

Authors:  Akihisa Kato; Yoshitaka Hirohata; Jun Arii; Yasushi Kawaguchi
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

5.  Evaluation of the role of the vaccinia virus uracil DNA glycosylase and A20 proteins as intrinsic components of the DNA polymerase holoenzyme.

Authors:  Kathleen A Boyle; Eleni S Stanitsa; Matthew D Greseth; Jill K Lindgren; Paula Traktman
Journal:  J Biol Chem       Date:  2011-05-13       Impact factor: 5.157

Review 6.  Orthopoxvirus targets for the development of antiviral therapies.

Authors:  Mark N Prichard; Earl R Kern
Journal:  Curr Drug Targets Infect Disord       Date:  2005-03

7.  Identification of inhibitors that block vaccinia virus infection by targeting the DNA synthesis processivity factor D4.

Authors:  Manunya Nuth; Lijuan Huang; Yih Ling Saw; Norbert Schormann; Debasish Chattopadhyay; Robert P Ricciardi
Journal:  J Med Chem       Date:  2011-04-19       Impact factor: 7.446

8.  Comparative whole genome sequence analysis of wild-type and cidofovir-resistant monkeypoxvirus.

Authors:  Jason Farlow; Mohamed Ait Ichou; John Huggins; Sofi Ibrahim
Journal:  Virol J       Date:  2010-05-28       Impact factor: 4.099

9.  Smallpox and pan-orthopox virus detection by real-time 3'-minor groove binder TaqMan assays on the roche LightCycler and the Cepheid smart Cycler platforms.

Authors:  David A Kulesh; Robert O Baker; Bonnie M Loveless; David Norwood; Susan H Zwiers; Eric Mucker; Chris Hartmann; Rafael Herrera; David Miller; Deanna Christensen; Leonard P Wasieloski; John Huggins; Peter B Jahrling
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

10.  A dimeric Rep protein initiates replication of a linear archaeal virus genome: implications for the Rep mechanism and viral replication.

Authors:  Muse Oke; Melina Kerou; Huanting Liu; Xu Peng; Roger A Garrett; David Prangishvili; James H Naismith; Malcolm F White
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.